CRYSTAL LAKE -- AptarGroup Inc. said its fiscal year 2020 sales grew 2%, with sales in its core markets equal to the prior year.
The company reported earnings per share of $3.21, a decrease of 12% compared to fiscal year 2019. Earnings were negatively impacted by the effects of the global pandemic on the beauty and beverage markets, the company said.
Aptar is a global leader in the design and manufacturing of a broad range of drug delivery, consumer product dispensing and active material solutions.
"Throughout the year, we remained committed to providing consumers and patients with the best products and services, while also focusing on the health and safety of our people," said Stephan B. Tanda, Aptar's president and CEO.
For the year ended Dec. 31, reported sales increased 2% to $2.93 billion compared to $2.86 billion reported a year ago, the company said. The negative effects of currency translation rates were more than offset by the positive contribution from business acquisitions, Aptar said.